Adapted Boxing and Photography in Haematology: Body Image and Self-Esteem
Condition(s) studied
Investigational drug(s) / intervention(s)
adapted boxing session: adapted boxing session and photography
Study summary
Although the benefits of adapted physical activity (APA) are well documented in the scientific literature, few studies have specifically examined the impact of adapted boxing on body image and self-esteem in patients with haematological conditions. The current approach relies on the empirical observations of healthcare professionals, but no systematic evaluation has been conducted to quantify the actual effects of this practice on patients. This project therefore aims to address this lack of data by rigorously and scientifically assessing the impact of a boxing session on patients' psychological and emotional well-being. The use of validated questionnaires (Rosenberg Scale, QIC, EORTC QLQ-C30) will provide objective and comparable measures12.
Eligibility
Primary outcome measure(s)
- Change in Body Image Score Assessed Using the QIC Questionnaire — Immediately before the adapted boxing session, immediately after the session, and 30 days after the session.
Body image will be assessed using the QIC questionnaire. Scores will be compared before and immediately after the adapted boxing session to evaluate changes in body image. - Patients' Perceptions of Body Image Assessed Through Semi-Structured Interviews — Immediately before the adapted boxing session, immediately after the session, and 30 days after the session.
Patients' perceptions and experiences of body image will be explored through semi-structured interviews. Interview data will be analyzed qualitatively to identify themes related to body image following the adapted boxing session.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital d'Hautepierre - CHRU Strasbourg | Strasbourg | France | Recruiting |
More University Hospital, Strasbourg, France trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07888959 on ClinicalTrials.gov ↗ ← All trials in France